Related Experiment Video

Updated: Aug 12, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

Catecholamine-induced vasoconstriction is sensitive to carbonic anhydrase I activation

I Puscas1, M Coltau, L Gilau

  • 1Romanian Medical Academy, Center for Research and Medical Assistance, Simleu Silvaniei, Salaj, Romania. ccam@netcompsj.ro

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|March 23, 2001
PubMed

Insights

Adrenergic agonists significantly boost carbonic anhydrase activity in erythrocytes and blood vessels. This activation is crucial for maintaining pH balance, facilitating signal transduction, and ultimately causing vasoconstriction.

Area of Science:

  • Biochemistry
  • Physiology
  • Pharmacology

Background:

  • Adrenergic agonists are key regulators of physiological processes.
  • Carbonic anhydrase isozymes (I and II) play vital roles in cellular functions.
  • The interplay between adrenergic signaling and carbonic anhydrase activity requires further elucidation.

Purpose of the Study:

  • To investigate the effect of alpha- and beta-adrenergic agonists on carbonic anhydrase I and II activity in erythrocytes.
  • To examine the relationship between adrenergic agonist-induced carbonic anhydrase activation and physiological responses, including blood pressure and vasoconstriction.

Main Methods:

  • Kinetic studies were performed to analyze enzyme activity.
  • Erythrocyte, clinical, and isolated vessel studies were conducted.
  • Measurements included carbonic anhydrase activity and blood pressure changes.

Main Results:

  • Adrenergic agonists (adrenaline, noradrenaline, isoprenaline, orciprenaline) significantly increased erythrocyte carbonic anhydrase activity.
  • Kinetic analysis revealed a non-competitive mechanism of action.
  • Clinical and vessel studies demonstrated a parallel increase in carbonic anhydrase I and blood pressure, suggesting a role in vasoconstriction.

Conclusions:

  • Adrenergic agonists activate carbonic anhydrase I and II in erythrocytes through a non-competitive mechanism.
  • A dual mechanism of action is proposed, involving both receptor-mediated signaling and direct carbonic anhydrase activation.
  • This activation is essential for maintaining intracellular pH, supporting stimulus-receptor coupling, and mediating vasoconstriction.

More Related Videos

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues08:41

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues

Published on: June 3, 2019

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

Related Concept Videos

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...